Viking Therapeutics targets obesity and MASH with high-risk prospects, trial concerns, and strong funding, but lags leaders ...

Metsera, Inc. is being acquired by Pfizer Inc. for up to $7.3 billion, driven by its innovative obesity drug pipeline. Click ...

Physicist Albert Einstein famously posited that if he only had an hour to crack a daunting problem, he'd devote 55 minutes to ...

Using a relatively young theory, a team of mathematicians has started to answer questions whose roots lie at the very ...

Akums highlights lacosamide as a versatile and trusted therapy for epilepsy: Our Bureau, Chennai Monday, September 22, 2025, 15:45 Hrs [IST] Akums Drugs & Pharmaceuticals is highl ...